During the past decade, Alaska Heart Institute conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 14 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 9 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alaska Heart Institute" #1 sponsor was "Abbott Medical Devices" with 4 trials, followed by "Medtronic" with 4 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 4 trials sponsored, "Brigham and Women's Hospital" with 2 trials sponsored and "CardioDx" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alaska Heart Institute" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "American College of Cardiology" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Boston VA Research Institute, Inc." with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Alaska Heart Institute" are "Heart Failure" (7 trials), "Atrial Fibrillation" (3 trials), "Cardiovascular Disease" (3 trials), "Cardiovascular Diseases" (3 trials) and "Arrhythmia" (2 trials). Many other conditions were trialed in "Alaska Heart Institute" in a lesser frequency.

Most popular intervention types in "Alaska Heart Institute" are "Device" (11 trials), "Drug" (8 trials), "Other" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "bococizumab (PF-04950615)" (2 trials), "AV Therapy Assessment-B301 investigational device" (1 trials), "Antiarrhythmic drug" (1 trials) and "Arctic Front™ Cardiac Cryoablation Catheter" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alaska Heart Institute" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Alaska Heart Institute". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Alaska Heart Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Alaska Heart Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".

Alaska Heart Institute has several departments that took part in Clinical trials: "Alaska Cardiovascular Research Foundation" - 3 trials